The pharmaceutical business is yet another dynamic venture, present globally and extremely important to research scientists, investors and the entire community at large. As in any other business, the success of any pharma company lies on 2 factors- investment potential and risk taking ability. In addition, the R&D portfolio becomes a huge numerator to ensure successful profit quotient.
So what efforts go behind the scene till a new drug hits the market? Do patients benefit ? Are they cured? How do we control health care costs? What are the new drugs in the making?
Dr.Shruti Bhat, an Expert in Pharmaceutical industry, brings to you some highlights from current pharma and clinical research news, views and data.
Aspirin may boost survival, cut risk of recurrence in breast cancer survivors.
A new study says breast cancer survivors who take aspirin regularly may be less likely to die or have their cancer return." The researchers found that "women who had been diagnosed with early breast cancer and who just happen to be taking aspirin, somewhere between two and five days, had a 50% reduction in dying of the breast cancer." In women who took "aspirin just once a week, there was no benefit," but, those who took "aspirin two to five times a week" experienced a 71 percent reduction in dying from a return of the cancer. ...
Discovery Laboratories to run additional preclinical trials for respiratory stress syndrome drug.
Following discussions with the FDA, "Discovery Laboratories Inc. said Tuesday it won't have to run new clinical trials of its respiratory stress syndrome treatment Surfaxin [lucinactant], which could save the company money and help get the drug approved sooner." ...
Additional trials may underscore prostate cancer drug's early successes.
Further tests have underlined abiraterone's "potential" as a prostate cancer drug, and "larger trials are underway." ...
Statins may increase diabetes risk.
According to a study published online Feb. 17 in The Lancet, statins may increase the risk of developing diabetes. After analyzing 13 studies of statins encompassing "more than 90,000 patients," researchers found that "the risk" for developing diabetes is "tied to the entire class of medications, and the danger increases with age." ...
Botox may help prevent some types of migraines.
Allergan Inc.'s Botox [botulinum toxin type A], given in the doses used to reduce facial wrinkles, may stop certain kinds of migraines that patients describe as crushing or 'eye-popping' more than other types," according to research published in the Archives of Dermatology. ....
Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
Expert at leading Pharmaceutical R&D.
Translates innovative concepts to PROFITS.